Paper33713588
Stability of sputum inflammatory phenotypes in childhood asthma during stable and exacerbation phases.
Tsang YP and 3 others. Pediatr Pulmonol, 2021. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Stability of sputum inflammatory phenotypes in childhood asthma during stable and exacerbation phases. Papers, record 33713588. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33713588
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Stability of sputum inflammatory phenotypes in childhood asthma during stable and exacerbation phases.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Sputum | Major topic |
| Eosinophils | |
| Humans | |
| Leukocyte Count | |
| Phenotype |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41090234 | Asthma Phenotype Progression in Children and Adolescents: A Single Center Experience. | Pediatr Pulmonol | 2025 | https://conductscience.org/library/papers/41090234 | PubMed |
| 40468299 | Sputum quality affects assessment of airway microbiology in childhood asthma. | Respir Res | 2025 | https://conductscience.org/library/papers/40468299 | PubMed |
| 40125574 | Non-T2 asthma. | Curr Opin Pulm Med | 2025 | https://conductscience.org/library/papers/40125574 | PubMed |
| 39508721 | Clinical Significance of Combined Detection of CCL22 and IL-1 as Potential New Bronchial Inflammatory Mediators in Children's Asthma. | Immun Inflamm Dis | 2024 | https://conductscience.org/library/papers/39508721 | PubMed |
| 38916810 | A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe Asthma. | Adv Ther | 2024 | https://conductscience.org/library/papers/38916810 | PubMed |
| 38697650 | Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies. | Eur Respir J | 2024 | https://conductscience.org/library/papers/38697650 | PubMed |
| 38337450 | Endotypes of Paediatric Cough-Do They Exist and Finding New Techniques to Improve Clinical Outcomes. | J Clin Med | 2024 | https://conductscience.org/library/papers/38337450 | PubMed |
| 38194205 | Assessment of Airway Inflammation by Induced Sputum in Children with Persistent Asthma. | Indian J Pediatr | 2024 | https://conductscience.org/library/papers/38194205 | PubMed |
| 37171821 | Current and Optimal Practices in Childhood Asthma Monitoring Among Multiple International Stakeholders. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37171821 | PubMed |
| 35584351 | Type 2 or Non-Type 2 Asthma Exacerbations? That Is the Question. | Am J Respir Crit Care Med | 2022 | https://conductscience.org/library/papers/35584351 | PubMed |
| 34834581 | Airway Wall Remodeling in Childhood Asthma-A Personalized Perspective from Cell Type-Specific Biology. | J Pers Med | 2021 | https://conductscience.org/library/papers/34834581 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33713588
GET https://conductscience.org/api/papers/v1/33713588/authors